Ptc Therapeutics (PTCT) Operating Income (QoQ) (2012 - 2026)
Ptc Therapeutics (PTCT) Operating Income (QoQ) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ptc Therapeutics |
6.51 Bn |
4.61 Bn |
244.52 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
163.01% |
| Dec 31, 2025 |
-2,465.68% |
| Sep 30, 2025 |
108.63% |
| Jun 30, 2025 |
-103.60% |
| Mar 31, 2025 |
697.47% |
| Dec 31, 2024 |
-197.91% |
| Sep 30, 2024 |
-35.54% |
| Jun 30, 2024 |
11.52% |
| Mar 31, 2024 |
-880.98% |
| Dec 31, 2023 |
104.93% |
| Sep 30, 2023 |
43.61% |
| Jun 30, 2023 |
-78.16% |
| Mar 31, 2023 |
41.29% |
| Dec 31, 2022 |
-193.81% |
| Sep 30, 2022 |
26.17% |
| Jun 30, 2022 |
-6.75% |
| Mar 31, 2022 |
-2.11% |
| Dec 31, 2021 |
8.97% |
| Sep 30, 2021 |
5.50% |
| Jun 30, 2021 |
-0.35% |
